ANI Pharmaceuticals, Inc. (ANIP) Q1 2026 Earnings Call

Investor webinar replay

Replay transcript excerpt

Good day, everyone, and welcome to today's ANI Pharmaceuticals, Inc. First Quarter twenty twenty six Earnings Results Call. Please note this call is being recorded. After the speakers' prepared remarks, there will be a question and answer session. If you'd like to ask a question during this time, simply press star, one, one on your telephone keypad It is now my pleasure to turn the conference over to Irina Koffler. Thank you, Liz. Welcome to ANI Pharmaceuticals First Quarter twenty twenty six Earnings Results Call. This is Irina Koffler, Investor Relations for ANI. With me on today's call are Nikhil Lalwani, President and Chief Executive Officer Stephen Carey, Senior Vice President and Chief Financial Officer and Chris Muth, Senior Vice President and Head of ANI's Rare Disease business. You can also access the webcast of this call through the Investors section of the ANI website at anipharmaceuticals.com. This call is accompanied by a slide deck that can be accessed by going to the Events section of the Investors page of our website. You can turn to our forward looking statements on Slide two. Before we begin, I would like to remind everyone that some statements we make today may be considered forward looking statements as defined by the Private Securities Litigation Reform Act. ANI cautions that these forward looking statements are subject to risks and uncertainties, including those noted in our press release issued this morning and our filings with the SEC that may cause actual results to differ materially from those projected in the forward looking statements. ANI specifically disclaims any intent or obligation to update these forward looking statements except as required by law. During this call, we will also refer to certain non GAAP financial measures. These no...